Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Akebia Therapeutics, Inc. AKBA

Healthcare  —  Drug Manufacturers Specialty & Generic
0.90 (0.02) (2.17%) as of 25 Sep
Market cap
$254.7M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending)
Download Excel — free account

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments 155.55 162.64 184.84 166.44

+8 more quarters
Receivables 53.51 62.54 47.03 66.22
Inventory 13.02 13.00 15.61 18.64
Total current assets 229.55 243.48 252.96 258.34
Property, Plant, Equpment (Net) 1.51 0.96 1.22 1.47
Goodwill and Intangible Assets (Total) 59.04 59.04 59.04 59.04
Long-term assets (Other) 53.75 56.57 59.68 40.46
Total non-current assets 120.11 119.04 123.61 105.82
Total Assets 349.66 362.52 376.57 364.15
Accounts Payable 9.42 8.39 21.19 10.09
Accrued Expenses 109.80 125.06 121.72 106.42
Current Part of Debt 24.81 12.50 — —
Current Revenue (Deferred) 6.17 4.50 2.68 3.88
Other current liabilities 10.67 23.45 17.36 12.99
Total current liabilities 160.87 173.88 162.94 133.38
Long Term Debt (Total) 24.75 36.40 48.25 47.64
Non-current Liabilities (Other) 134.62 124.87 132.77 141.54
Total non-current liabilities 163.78 161.26 181.02 189.18
Total liabilities 324.64 335.15 343.96 322.56
Additional Paid In Capital 1,726.68 1,720.13 1,716.31 1,713.05
Common Stock (Net) 0.00 0.00 0.00 0.00
Retained Earnings (1,701.67) (1,692.76) (1,683.70) (1,671.46)
Common Equity (Total) 25.02 27.37 32.61 41.59
Shareholders Equity (Total) 25.02 27.38 32.61 41.59
Shareholders Equity and Liabilities (Total) 349.66 362.52 376.57 364.15
Shares (Common) 271.74 267.90 265.43 265.23
Shareholders Equity (Tangible) (34.03) (31.67) (26.43) (17.45)
Net Debt (105.98) (113.75) (136.59) (118.80)
Total Debt 49.56 48.89 48.25 47.64

Fold the line items

In millions of $ except per-share values · columns are period end dates